Nutra Pharma Valuation
| NPHC Stock | USD 0.0001 0.00 0.00% |
Nutra Pharma seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Nutra Pharma Corp from analyzing the firm fundamentals such as Shares Outstanding of 7.6 B, return on asset of -1.13, and Operating Margin of (5.58) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Nutra Pharma's price fluctuation is out of control at this time. Calculation of the real value of Nutra Pharma Corp is based on 3 months time horizon. Increasing Nutra Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Nutra Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nutra Pink Sheet. However, Nutra Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 9.6E-5 | Hype 9.9E-5 | Naive 1.43E-4 |
The real value of Nutra Pink Sheet, also known as its intrinsic value, is the underlying worth of Nutra Pharma Corp Company, which is reflected in its stock price. It is based on Nutra Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Nutra Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Nutra Pharma Corp helps investors to forecast how Nutra pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nutra Pharma more accurately as focusing exclusively on Nutra Pharma's fundamentals will not take into account other important factors: Nutra Pharma Total Value Analysis
Nutra Pharma Corp is now forecasted to have valuation of 10.33 M with market capitalization of 759.68 K, debt of 517.18 K, and cash on hands of 10.45 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nutra Pharma fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.33 M | 759.68 K | 517.18 K | 10.45 K |
Nutra Pharma Investor Information
The company had not issued any dividends in recent years. Nutra Pharma Corp had 1:40 split on the 18th of May 2015. Based on the key measurements obtained from Nutra Pharma's financial statements, Nutra Pharma Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Nutra Pharma Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nutra Pharma has an asset utilization ratio of 17.2 percent. This indicates that the Company is making $0.17 for each dollar of assets. An increasing asset utilization means that Nutra Pharma Corp is more efficient with each dollar of assets it utilizes for everyday operations.Nutra Pharma Ownership Allocation
Nutra Pharma Corp maintains a total of 7.6 Billion outstanding shares. Roughly 98.97 % of Nutra Pharma outstanding shares are held by general public with 1.02 pct. owned by insiders and only 0.007 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Nutra Pharma Profitability Analysis
The company reported the previous year's revenue of 51.9 K. Net Loss for the year was (769.18 K) with profit before overhead, payroll, taxes, and interest of 8.47 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nutra Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nutra Pharma and how it compares across the competition.
About Nutra Pharma Valuation
The pink sheet valuation mechanism determines Nutra Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of Nutra Pharma. We calculate exposure to Nutra Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nutra Pharma's related companies.Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company was incorporated in 2000 and is based in Plantation, Florida. NUTRA PHARMA operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.
8 Steps to conduct Nutra Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nutra Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nutra Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nutra Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nutra Pharma's revenue streams: Identify Nutra Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nutra Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nutra Pharma's growth potential: Evaluate Nutra Pharma's management, business model, and growth potential.
- Determine Nutra Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nutra Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Nutra Pharma Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 6.6 B | |
| Quarterly Earnings Growth Y O Y | -0.964 | |
| Retained Earnings | -68.6 M |
Complementary Tools for Nutra Pink Sheet analysis
When running Nutra Pharma's price analysis, check to measure Nutra Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutra Pharma is operating at the current time. Most of Nutra Pharma's value examination focuses on studying past and present price action to predict the probability of Nutra Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutra Pharma's price. Additionally, you may evaluate how the addition of Nutra Pharma to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Commodity Directory Find actively traded commodities issued by global exchanges |